Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans.
Christine A Rabinak, Mike Angstadt, Maryssa Lyons, Shoko Mori, Mohammed R. Milad, Israel Liberzon, K Luan Phan
Neurobiology of Learning and Memory September 2014 DOI: 10.1016/j.nlm.2013.09.009 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized, double-blind, placebo-controlled, between-subjects fMRI study Peer reviewed |
|---|---|
| Sample size | 28 |
| Population | Healthy adult volunteers |
| Intervention | Dronabinol (synthetic THC) |
| Duration | Extinction memory recall tested 24 h after extinction learning |
| Keywords | Amygdala Extinction Hippocampus Ventromedial prefrontal cortex FMRI Δ9-tetrahydrocannabinol |
| Key points | Participants who received THC before extinction learning showed increased ventromedial prefrontal cortex and hippocampus activation to a previously extinguished conditioned stimulus during extinction memory recall 24 hours later, compared with placebo recipients. The authors state this is the first evidence that pre-extinction THC modulates prefrontal-limbic circuits during fear extinction in humans and propose the cannabinoid system as a potential target for enhancing exposure-based therapy in PTSD. |
Abstract
Pre-extinction administration of Δ9-tetrahydrocannibinol (THC) facilitates recall of extinction in healthy humans, and evidence from animal studies suggest that this likely occurs via enhancement of the cannabinoid system within the ventromedial prefrontal cortex (vmPFC) and hippocampus (HIPP), brain structures critical to fear extinction. However, the effect of cannabinoids on the underlying neural circuitry of extinction memory recall in humans has not been demonstrated. We conducted a functional magnetic resonance imaging (fMRI) study using a randomized, double-blind, placebo-controlled, between-subjects design (N=14/group) coupled with a standard Pavlovian fear extinction paradigm and an acute pharmacological challenge with oral dronabinol (synthetic THC) in healthy adult volunteers. We examined the effects of THC on vmPFC and HIPP activation when tested for recall of extinction learning 24 h after extinction learning. Compared to subjects who received placebo, participants who received THC showed increased vmPFC and HIPP activation to a previously extinguished conditioned stimulus (CS+E) during extinction memory recall. This study provides the first evidence that pre-extinction administration of THC modulates prefrontal-limbic circuits during fear extinction in humans and prompts future investigation to test if cannabinoid agonists can rescue or correct the impaired behavioral and neural function during extinction recall in patients with PTSD. Ultimately, the cannabinoid system may serve as a promising target for innovative intervention strategies (e.g. pharmacological enhancement of exposure-based therapy) in PTSD and other fear learning-related disorders.
Citations in the library
Cited by 19
- Reviewing the Potential of Psychedelics for the Treatment of PTSD The International Journal of Neuropsychopharmacology March 12, 2020
- The neuropsychopharmacology of cannabis: A review of human imaging studies Pharmacology & Therapeutics October 20, 2018
- Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry. Expert Review of Neurotherapeutics 2022
- The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier? Cureus October 31, 2022
- Phytochemical interventions for post-traumatic stress disorder: A cluster co-occurrence network analysis using CiteSpace. Journal of integrative medicine July 1, 2023
and 14 more in the library
Cites 5
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing Archives of General Psychiatry 2009
- Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect. Journal of Neural Transmission June 2012
- Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology November 18, 2009
- Gene-environment interplay between cannabis and psychosis. Schizophrenia Bulletin November 1, 2008
- Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans Journal of Neuroscience March 5, 2008